In order to identify compounds with potential toxicity problems, particular attention is paid to structural alerts, which are high chemical reactivity molecular fragments or fragments that can be transformed via bioactivation by human enzymes into fragments with high chemical reactivity. The concept has been introduced in order to reduce the likelihood that future candidate substances as pharmaceuticals will have undesirable toxic effects. A significant proportion (∼78–86%) of drugs characterized by residual toxicity contain structural alerts; there is also evidence indicating the formation of active metabolites as a causal factor for the toxicity of 62–69% of these molecules. On the other hand, the pharmacological action of certain drugs d...
Toxicity testing of chemicals is currently undergoing its largest ever paradigm shift, moving toward...
Molecular initiating events (MIEs) can be boiled down to chemical interactions. Chemicals that inter...
Toxicity accounts for approximately 30 % of expensive, late stage failures in development. Therefore...
Metabolic activation of new chemical entities to reactive intermediates is routinely monitored in dr...
Reactive metabolites are widely accepted as playing a pivotal role in causing idiosyncratic adverse ...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity towa...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity towa...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
Structural alerts are commonly used in drug discovery to identify molecules likely to form reactive ...
A number of drugs have been withdrawn from the market or severely restricted in their use because of...
A number of drugs have been withdrawn from the market or severely restricted in their use because of...
Toxicity testing of chemicals is currently undergoing its largest ever paradigm shift, moving toward...
Molecular initiating events (MIEs) can be boiled down to chemical interactions. Chemicals that inter...
Toxicity accounts for approximately 30 % of expensive, late stage failures in development. Therefore...
Metabolic activation of new chemical entities to reactive intermediates is routinely monitored in dr...
Reactive metabolites are widely accepted as playing a pivotal role in causing idiosyncratic adverse ...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity towa...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity towa...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
The normal metabolism of drugs can generate metabolites that have intrinsic chemical reactivity tow...
Structural alerts are commonly used in drug discovery to identify molecules likely to form reactive ...
A number of drugs have been withdrawn from the market or severely restricted in their use because of...
A number of drugs have been withdrawn from the market or severely restricted in their use because of...
Toxicity testing of chemicals is currently undergoing its largest ever paradigm shift, moving toward...
Molecular initiating events (MIEs) can be boiled down to chemical interactions. Chemicals that inter...
Toxicity accounts for approximately 30 % of expensive, late stage failures in development. Therefore...